皓宸医疗(002622.SZ)：2025年中报净利润为-2375.11万元，同比由盈转亏

Financial Performance - The company's total revenue for the first half of 2025 was 314 million yuan, ranking 39th among disclosed peers, representing a decrease of 68.37 million yuan or 17.90% year-on-year [1] - The net profit attributable to shareholders was -23.75 million yuan, ranking 44th among disclosed peers, a decrease of 24.30 million yuan or 4391.18% year-on-year [1] - The net cash flow from operating activities was -27.59 million yuan, ranking 43rd among disclosed peers, a decrease of 34.59 million yuan or 494.15% year-on-year [1] Financial Ratios - The latest debt-to-asset ratio was 71.73%, ranking 47th among disclosed peers, an increase of 0.64 percentage points from the previous quarter and 2.00 percentage points year-on-year [3] - The latest gross profit margin was 43.16%, ranking 18th among disclosed peers, an increase of 4.65 percentage points from the previous quarter but a decrease of 2.90 percentage points year-on-year [3] - The latest return on equity (ROE) was -6.37%, ranking 48th among disclosed peers, a decrease of 6.50 percentage points year-on-year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share was -0.03 yuan, ranking 41st among disclosed peers, a decrease of 0.03 yuan or 4142.86% year-on-year [3] - The latest total asset turnover ratio was 0.21 times, ranking 25th among disclosed peers, a decrease of 0.03 times or 13.82% year-on-year [3] - The latest inventory turnover ratio was 3.43 times, ranking 23rd among disclosed peers, an increase of 0.16 times, marking five consecutive years of growth, and an increase of 4.91% year-on-year [3]